Original story published here: https://www.newcannabisventures.com/public-companies-dominate-the-rapidly-growing-florida-medical-cannabis-market/
Voters in Florida approved expanded medical cannabis legalization nearly four years ago after failing to do so in 2014, with 71% voting in favor of Amendment 2. The program has become one of the most successful limited license medical cannabis programs to date, with over 361K active patients as of July 2nd. In this review, we take a look at the history of Florida’s cannabis program, the existing marketplace and potential for future growth.
Prior to the current program, Florida permitted a limited number of patients to use low-THC strains, with several growers already operating after a 2015 application process that saw the state approve seven after receiving 28 applications from nurseries.
The approved nurseries for Low-THC included: Alpha Foliage (Southwest Region), Chestnut Hill Tree Farm (Northeast Region), Costa Nursery Farms (Southeast Region), Hackney Nursery Company (Northwest Region), Knox Nursery (Central Region), McCrory’s Sunny Hill Nursery (Central Region) and San Felasco Nurseries d/b/a Grandiflora (Northeast Region). McCrory’s Sunny Hill Nursery and San Felasco Nurseries were both rejected initially but approved after successful appeal. Many of those initially denied in the Low-THC program ultimately received licenses later.
Alpha Foliage became known later as Surterra, now Parallel. Chestnut Hill is now part of Liberty Health Sciences (CSE: LHS) (CSE: LHSIF). Costa Nursery Farms became Modern Health Concepts, now part of Curaleaf Holdings (CSE: CURA) (OTC: CURLF), Hackney Nursery’s license is now owned by Trulieve (CSE: TRUL) (OTC: TCNNF). Knox Nursery’s license is now owned by Cansortium (CSE: TIUM.U) (OTC: CNTMF) and is known as Fluent. McCrory’s Sunny Hill Nursery became GrowHealthy, which was acquired by iAnthus Capital (CSE: IAN) (OTC: ITHUF). San Felasco’s license is now held by Harvest Health and Recreation (CSE: HARV) (OTC: HRVSF).
Amendment 2 detailed several qualifying conditions. The current ones include:
The Florida Department of Health supervises the program, which is overseen by its Office of Medical Marijuana Use (OMMU). Florida doesn’t allow home-grow. Patients are able to access medical cannabis through dispensaries, and delivery is an option.
A major improvement was made in early 2019, when the ban on smokable flower was lifted after having been overturned by a court in May 2018. A change that lies ahead, likely deferred by the pandemic, is the addition of edibles
Florida has 22 medical marijuana treatment centers (MMTCs) currently approved, though not all are operational. Authorizations are made in three stages, including cultivation, processing and dispensing. Of the 22 MMTCs, 15 are permitted to dispense. Of the remaining 7, 3 have cultivation authorization, 2 have processing authorization and 2 are listed as “n/a.” The state isn’t accepting MMTC applications at this time.
Florida provides very robust data on a weekly basis. As of July 2nd, the OMMU reported 361,826 patients, which represents 1.7% of the state’s total population. The level of disclosure has improved greatly since the OMMU began sharing it in 2016. At the end of 2017, the state had 41,724 approved patients, which increased by 301% in 2018 and 79% in 2019. Over the past year, while growth has slowed, it remains in excess of 50%:
During April and May, growth in patients slowed, most likely due to the pandemic, but the four-week growth rate has sharply accelerated since Memorial Day:
Each week, OMMU details the number of dispensing locations, which now totals 255, and breaks them down by MMTC. Additionally, it provides the amount of Medical Marijuana dispensed (in milligrams of THC), the amount of Low-THC Cannabis (in milligrams of CBD) and Marijuana in a Form for Smoking (in ounces):
The 15 dispensing MMTCs include the 7 detailed above, of which 6 are public companies, as well as 8 additional ones. Of the additional MMTCs, 5 are publicly traded, including Acreage Holdings (CSE: ACRG.U) (OTC: ACRGF), which owns The Botanist, Bluma Wellness (CSE: BWEL), which operates as One Plant, Columbia Care (CSE: CCHW) (NEO: CCHW) (OTC: CCHWF), Green Thumb Industries (CSE: GTII) (OTC: GTBIF), and MedMen (CSE: MMEN) (OTC: MMNFF). Financial constraints at several of these companies could impede their growth in the market.
Trulieve is the clear market leader, with 20% of the dispensaries and substantial leadership in both extracted products and flower, and it derives almost all of its revenue from Florida. In Q2, it generated sales of $96.1 million. It has added 9 stores this year. Privately held Surterra Wellness has added two dispensaries and aggressively expanded its sales of flower. Curaleaf hasn’t added any dispensaries this year and has seen its share of the market decline in terms of units relative to Trulieve. Liberty Health Sciences derives all of its revenue from Florida and has added 3 dispensaries this year. In its fiscal Q4 ending 2/29, it generated revenue of C$17.8 million (about US$13 million).
Overall unit growth has been robust in 2020. In the most recent quarter, Medical Marijuana has grown almost 18% from the prior quarter compared to almost 16% comparing Q1 to Q4. In the most recent week, it expanded 57% from a year ago. Flower growth has been more robust at almost 41%, though it slowed from almost 47% growth sequentially during Q1.
At present, Florida is fully vertically integrated, with no wholesale activities permitted, and the market could become more efficient with a change. Many MMTCs have struggled to ramp up production, and several MMTCs would likely be better off buying wholesale than continuing to self-supply their dispensaries. Even without a change in wholesale, expanded production capacity could help meet what appears to be continuing robust patient growth. The addition of edibles, which is long overdue, is likely to boost the market as well. Rules were proposed in December, but they haven’t yet been adopted.
Looking ahead, Florida could legalize for adult-use through the ballot initiative process in 2022. The state requires 60% for an amendment to pass, making it somewhat challenging. Make It Legal Florida has proposed an amendment that would allow MMTCs to sell to any adult 21 years of age or older. There is no discussion of taxation or home-grow in the amendment. It’s also possible that the legislature could move to legalize. Earlier this year, Republican state senator filed SB 1860, but it was withdrawn from consideration in March.
With or without adult-use, the very successful Florida medical cannabis market continues to rapidly expand. Cannabis investors are able to participate in the growth through several public companies operating in the market, including two that derive the vast majority of their revenue from it.
Note: We have revised this article to correct an earlier error regarding the San Felasco license
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.Exclusive article by Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email